Germany’s New Government Will Maintain Price Freeze And Slash Free Pricing Period
Executive Summary
Big changes are in store on the drug pricing front in Germany. Further reforms could depend on who is appointed health minister.
You may also be interested in...
Germany To Honor Pledge To Cut Spending On Medicines
Germany looks set to introduce new measures to curb pharmaceutical spending, including higher mandatory rebates for outpatient drugs and combination products. It will also lower the threshold at which orphan drugs must undergo a benefit assessment.
Added Benefit For Orphans Is ‘Fictitious’ Says German HTA Body
Industry has warned that reforming the system for evaluating orphan drugs could have serious consequences for patient access.
Germany: Drug Spending Crack Down Could Mean Tougher Reference Pricing Measures
Pricing reforms in Germany could have a ripple effect elsewhere as other countries look for inspiration on how to rein in pharmaceutical spending.